$REGN REGENERON PHARMACEUTICALS, INC. Insider Trading Week 50/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. in week 50/2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Option Exercise | M | 52.03 | 3,450 | 179,504 | 10,326 | |
| Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Option Exercise | M | 21.25 | 675 | 14,344 | 500 | |
| Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 362.45 | 200 | 72,490 | 7,096 | 7.3 K to 7.1 K (-2.74 %) |
| Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 361.65 | 100 | 36,165 | 7,296 | 7.4 K to 7.3 K (-1.35 %) |
| Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 360.40 | 500 | 180,200 | 7,396 | 7.9 K to 7.4 K (-6.33 %) |
| Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 359.38 | 200 | 71,876 | 7,896 | 8.1 K to 7.9 K (-2.47 %) |
| Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 358.27 | 200 | 71,654 | 8,096 | 8.3 K to 8.1 K (-2.41 %) |
| Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 357.50 | 200 | 71,500 | 8,296 | 8.5 K to 8.3 K (-2.35 %) |
| Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 356.27 | 348 | 123,982 | 8,496 | 8.8 K to 8.5 K (-3.93 %) |
| Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Sell | S | 355.14 | 100 | 35,514 | 8,844 | 8.9 K to 8.8 K (-1.12 %) |
| Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Buy | M | 21.25 | 675 | 14,344 | 8,944 | 8.3 K to 8.9 K (+8.16 %) |
| Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Payment of Exercise | F | 364.42 | 1,602 | 583,801 | 8,269 | 9.9 K to 8.3 K (-16.23 %) |
| Dec 20 2018 | REGN | REGENERON PHARMACE ... | Fenimore Christopher R. | VP Controller | Buy | M | 52.03 | 3,450 | 179,504 | 9,871 | 6.4 K to 9.9 K (+53.73 %) |
| Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Option Exercise | M | 16.80 | 94,048 | 1,580,006 | 0 | |
| Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Option Exercise | M | 16.80 | 150,000 | 2,520,000 | 94,048 | |
| Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Gift | G | 0.00 | 118,993 | 0 | 602,594 | 483.6 K to 602.6 K (+24.61 %) |
| Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Gift | G | 0.00 | 118,993 | 0 | 0 | 119 K to 0 (-100.00 %) |
| Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Payment of Exercise | F | 377.31 | 48,192 | 18,183,324 | 118,993 | 167.2 K to 119 K (-28.83 %) |
| Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Buy | M | 16.80 | 94,048 | 1,580,006 | 167,185 | 73.1 K to 167.2 K (+128.59 %) |
| Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Payment of Exercise | F | 377.31 | 76,863 | 29,001,179 | 73,137 | 150 K to 73.1 K (-51.24 %) |
| Dec 17 2018 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Buy | M | 16.80 | 150,000 | 2,520,000 | 150,000 | 0 to 150 K |